Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Perioperatīvie neatliekamie stāvokļi anestezioloģijā
Ozoliņa, A. (Member of the Working Group), Junga, A. (Member of the Working Group), Ročāns, R. P. (Member of the Working Group), Lejnieks, A. (Member of the Working Group), Strēlnieks, A. (Member of the Working Group), Pudulis, J. (Member of the Working Group), Aleksejeva, M. (Member of the Working Group), Petrovs, A. (Member of the Working Group), Bīne, E. (Member of the Working Group), Oborina, A. (Member of the Working Group), Moskaļenko, K. J. (Member of the Working Group), Kļečetņikova, A. (Member of the Working Group), Putniņa, L. (Member of the Working Group), Bērze-Bērziņa, K. (Member of the Working Group) & Dreimane, K. (Member of the Working Group), 2025, 61 p. Rīga : Rīgas Austrumu klīniskās universitātes slimnīcas Mācību centrs.Research output: Guidelines, algorithms, methodologies & Other contribution › Guidelines, algorithms, and methodologies › Research
-
Kardioonkoloģijas koncepts. Imūnterapijas kardiotoksicitāte un pacientu uzraudzība
Strēlnieks, A. & Kokina, B., 27 Apr 2023, Doctus, aprīlis, p. 10-15.Research output: Contribution to specialist publication › Specialist article › Research
Open Access -
Spironolactone for atrial fibrillation recurrence reduction after successful electrical cardioversion
Kokina, B., Kalējs, O., Mača-Kalēja, A., Strēlnieks, A., Jubele, K. & Lejnieks, A., 2023, In: Medicina (Kaunas). 59, Suppl.2, p. 220Research output: Contribution to journal › Meeting Abstract › peer-review
Open AccessFile4 Downloads (Pure) -
Indirect antiarrhythmic effects of renin-angiotensin-aldosterone system inhibition for arrhythmia recurrence prevention after electrical cardioversion for persistent atrial fibrillation
Strēlnieks, A., Kokina, B., Jubele, K., Pupkeviča, I., Rudaka, I., Kamzola, G., Kalējs, O. & Lejnieks, A., 24 Mar 2021, p. 137.Research output: Contribution to conference › Abstract › peer-review
-
Inotropic function of myocardium in patients with persistent form of atrial fibrillation receiving antiarrhythmic drugs class Ic
Sokolova, E., Strēlnieks, A., Kokina, B., Rudzītis, A., Lejnieks, A. & Kalējs, O., 24 Mar 2021, p. 138.Research output: Contribution to conference › Abstract › peer-review
Activities
- 1 Poster presentation
-
Spironolactone for Atrial Fibrillation Recurrence Reduction after Successful Electrical Cardioversion
Kokina, B. (Speaker), Kalējs, O. (Co-author), Mača-Kalēja, A. (Co-author), Strēlnieks, A. (Co-author), Jubele, K. (Co-author) & Lejnieks, A. (Co-author)
29 Mar 2023Activity: Talk or presentation types › Poster presentation